Structural determinants of efficacy at A₃ adenosine receptors: modification of the ribose moietyGAO, Zhan-Guo; LAK SHIN JEONG; GROSS, Ariel S et al.Biochemical pharmacology. 2004, Vol 67, Num 5, pp 893-901, issn 0006-2952, 9 p.Article

Pharmacological and therapeutic effects of A₃ adenosine receptor agonistsFISHMAN, Pnina; BAR-YEHUDA, Sara; LIANG, Bruce T et al.Drug discovery today. 2012, Vol 17, Num 7-8, pp 359-366, issn 1359-6446, 8 p.Article

Balance of purines may determine life or death of retinal ganglion cells as A₃ adenosine receptors prevent loss following P2X₇ receptor stimulationXIULAN ZHANG; MEI ZHANG; LATIES, Alan M et al.Journal of neurochemistry. 2006, Vol 98, Num 2, pp 566-575, issn 0022-3042, 10 p.Article

The A₃ adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cellsMEI ZHANG; HUILING HU; XIULAN ZHANG et al.Neurochemistry international. 2010, Vol 56, Num 1, pp 35-41, issn 0197-0186, 7 p.Article

A topological function based on spectral moments for predicting affinity toward A₃ adenosine receptorsPEREZ GONZALEZ, Maykel; TERAN, Carmen; TEIJEIRA, Marta et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 5, pp 1291-1296, issn 0960-894X, 6 p.Article

BCUT descriptors for predicting affinity toward A₃ adenosine receptorsPEREZ GONZALEZ, Maykel; TERAN, Carmen; TEIJEIRA, Marta et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 15, pp 3491-3495, issn 0960-894X, 5 p.Article

Medicinal Chemistry of the A₃ Adenosine Receptor: Agonists, Antagonists, and Receptor EngineeringJACOBSON, Kenneth A; KLUTZ, Athena M; TOSH, Dilip K et al.Handbook of experimental pharmacology. 2009, Vol 193, pp 123-159, issn 0171-2004, 37 p.Article

ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptorsYU CHEN; CORRIDEN, Ross; INOUE, Yoshiaki et al.Science (Washington, D.C.). 2006, Vol 314, Num 5806, pp 1792-1795, issn 0036-8075, 4 p.Article

IB-MECA and cardioprotectionZHELONG XU; YEONGHO JANG; MUELLER, Robert A et al.Cardiovascular drug reviews (Print). 2006, Vol 24, Num 3-4, pp 227-238, issn 0897-5957, 12 p.Article

Adenosine A₃ receptors are located in neurons of the rat hippocampusLOPES, Luisa V; REBOLA, Nelson; PINHEIRO, Paulo C et al.Neuroreport (Oxford). 2003, Vol 14, Num 12, pp 1645-1648, issn 0959-4965, 4 p.Article

Caspase Inhibition Via A₃ Adenosine Receptors: A New Cardioprotective Mechanism Against Myocardial InfarctionHUSSAIN, Afthab; AHMED MAYEL GHARANEI; AARONDEEP SINGH NAGRA et al.Cardiovascular drugs and therapy. 2014, Vol 28, Num 1, pp 19-32, issn 0920-3206, 14 p.Article

Synthesis and evaluation of new N⁶-substituted adenosine-5'-N-methylcarbox- amides as A₃ adenosine receptor agonistsDEVINE, Shane M; GREGG, Alison; FIGLER, Heidi et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 9, pp 3078-3087, issn 0968-0896, 10 p.Article

Design and synthesis of N⁶-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A₃ adenosine receptor agonistsWON JUN CHOI; HYUK WOO LEE; HEA OK KIM et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 23, pp 8003-8011, issn 0968-0896, 9 p.Article

A₃ Adenosine Receptor: Pharmacology and Role in DiseaseBOREA, P. A; GESSI, S; BAR-YEHUDA, S et al.Handbook of experimental pharmacology. 2009, Vol 193, pp 297-327, issn 0171-2004, 31 p.Article

Swelling-activated chloride channels in aqueous humour formation : on the one side and the otherDO, C. W; CIVAN, M. M.Acta physiologica (Print). 2006, Vol 187, Num 1-2, pp 345-352, issn 1748-1708, 8 p.Conference Paper

A novel adenosine analog, thio-C1-IB-MECA, induces G₀/G₁ cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cellsLEE, Eun-Jin; MIN, Hye-Young; CHUNG, Hwa-Jin et al.Biochemical pharmacology. 2005, Vol 70, Num 6, pp 918-924, issn 0006-2952, 7 p.Article

A3 adenosine receptor agonist potentiates natural killer cell activityHARISH, Arie; HOHANA, Gil; FISHMAN, Pnina et al.International journal of oncology. 2003, Vol 23, Num 4, pp 1245-1249, issn 1019-6439, 5 p.Article

Allosteric enhancers for adenosine receptorsOLSSON, Ray A.Drug development research. 2003, Vol 58, Num 4, pp 493-495, issn 0272-4391, 3 p.Conference Paper

Affinity prediction on A₃ adenosine receptor antagonists: The chemometric approachLUAN, Feng; MELO, André; BORGES, Fernanda et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 22, pp 6853-6859, issn 0968-0896, 7 p.Article

Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A₃ adenosine receptorsHYUK WOO LEE; HEA OK KIM; WON JUN CHOI et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 19, pp 7015-7021, issn 0968-0896, 7 p.Article

Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A₃ adenosine receptor antagonistsPAL, Shantanu; WON JUN CHOI; LAK SHIN JEONG et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 10, pp 3733-3738, issn 0968-0896, 6 p.Article

Adenosine A₃ receptor activation modulates the capillary endothelial glycocalyxPLATTS, Steven H; DULING, Brian R.Circulation research. 2004, Vol 94, Num 1, pp 77-82, issn 0009-7330, 6 p.Article

Binding thermodynamics at the human A₃ adenosine receptorMERIGHI, Stefania; VARANI, Katia; GESSI, Stefania et al.Biochemical pharmacology. 2002, Vol 63, Num 2, pp 157-161, issn 0006-2952Article

Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cellsFISHMAN, Pnina; MADI, Lea; BAR-YEHUDA, Sara et al.Oncogene (Basingstoke). 2002, Vol 21, Num 25, pp 4060-4064, issn 0950-9232, 5 p.Article

ENHANCED NEURODEGENERATION AFTER A HIGH DOSE OF METHAMPHETAMINE IN ADENOSINE A3 RECEPTOR NULL MUTANT MICESHEN, H; LUO, Y; YU, S.-J et al.Neuroscience. 2011, Vol 194, pp 170-180, issn 0306-4522, 11 p.Article